These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35256601)

  • 1. LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease.
    Zou D; Liu L; Zeng Y; Wang H; Dai D; Xu M
    Cell Death Discov; 2022 Mar; 8(1):103. PubMed ID: 35256601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6.
    Huang P; Huang FZ; Liu HZ; Zhang TY; Yang MS; Sun CZ
    Metabolism; 2019 May; 94():1-8. PubMed ID: 30711569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
    Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
    J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-content hydrogen water-induced downregulation of miR-136 alleviates non-alcoholic fatty liver disease by regulating Nrf2 via targeting MEG3.
    Wang X; Wang J
    Biol Chem; 2018 Mar; 399(4):397-406. PubMed ID: 29261513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
    Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
    Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
    J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA Meg3 Regulates Mafa Expression in Mouse Beta Cells by Inactivating Rad21, Smc3 or Sin3α.
    Wang N; Zhu Y; Xie M; Wang L; Jin F; Li Y; Yuan Q; De W
    Cell Physiol Biochem; 2018; 45(5):2031-2043. PubMed ID: 29529600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
    Zhang L; Zhang Z; Li C; Zhu T; Gao J; Zhou H; Zheng Y; Chang Q; Wang M; Wu J; Ran L; Wu Y; Miao H; Zou X; Liang B
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):697-724. PubMed ID: 33075563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
    Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
    Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice.
    Yang Y; Zhang W; Wu X; Wu J; Sun C; Luo F; Pei Z
    Can J Gastroenterol Hepatol; 2021; 2021():8894685. PubMed ID: 33542911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis.
    Cui J; Wang Y; Xue H
    Bioengineered; 2022 Apr; 13(4):8370-8381. PubMed ID: 35322757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of endothelial cell function and arteriogenesis by MEG3:EZH2 epigenetic regulation of integrin expression.
    Dunn-Davies H; Dudnakova T; Nogara A; Rodor J; Thomas AC; Parish E; Gautier P; Meynert A; Ulitsky I; Madeddu P; Caporali A; Baker A; Tollervey D; Mitić T
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102173. PubMed ID: 38617973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenosides Rc, as a novel SIRT6 activator, protects mice against high fat diet induced NAFLD.
    Yang Z; Yu Y; Sun N; Zhou L; Zhang D; Chen H; Miao W; Gao W; Zhang C; Liu C; Yang X; Wu X; Gao Y
    J Ginseng Res; 2023 May; 47(3):376-384. PubMed ID: 37252281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis.
    Zhu Y; Hu S; Pan X; Gopoju R; Cassim Bawa FN; Yin L; Xu Y; Zhang Y
    Cells; 2023 Aug; 12(15):. PubMed ID: 37566087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 Promotes PPARα/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206/ARNT Axis.
    Xiang J; Deng YY; Liu HX; Pu Y
    Front Bioeng Biotechnol; 2022; 10():858558. PubMed ID: 35769097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
    Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
    Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MEG3 Restrains Hepatic Lipogenesis via the FOXO1 Signaling Pathway in HepG2 Cells.
    Meng X; Long M; Yue N; Li Q; Chen J; Zhao H; Deng W
    Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38713402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway.
    Chi Y; Gong Z; Xin H; Wang Z; Liu Z
    J Transl Med; 2020 Mar; 18(1):126. PubMed ID: 32169080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.